This Article Full Text Full Text (PDF) Correction (v42,pe5) All Versions of this Article: 41/6/1240    most recent 01.HYP.0000073581.74107.22v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Piccirillo, G. Articles by Marigliano, V. Search for Related Content PubMed PubMed Citation Articles by Piccirillo, G. Articles by Marigliano, V.

(Hypertension. 2003;41:1240.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Influence of Vitamin C on Baroreflex Sensitivity in Chronic Heart Failure

Gianfranco Piccirillo; Marialuce Nocco; Antonio Moisè; Marco Lionetti; Camilla Naso; Silvia di Carlo; Vincenzo Marigliano

From Dipartimento di Scienze dell’Invecchiamento, Policlinico Umberto I, Università "La Sapienza," Rome, Italy.

Correspondence to Dr Gianfranco Piccirillo, Dipartimento di Scienze dell’Invecchiamento, I Clinica Medica, Policlinico Umberto I, 00161 Rome, Italy. E-mail gianfranco.piccirillo{at}uniroma1.it

Chronic heart failure (CHF) reduces baroreflex sensitivity. Low baroreflex sensitivity, a risk factor for sudden death, could arise partly from CHF-dependent endothelial dysfunction. Vitamin C at high doses has a protective role against CHF-related endothelial damage. This study was conducted to investigate the effect of vitamin C on baroreflex sensitivity in CHF. A study group of 33 subjects with CHF secondary to postischemic dilated cardiomyopathy with an ejection fraction 35% and a control group (11 subjects) underwent assessment of baroreflex sensitivity by the phenylephrine method and an autonomic nervous system study by power spectral analysis. Variables were assessed after infusion of placebo and high doses of vitamin C (2.5 mg). In subjects with CHF, baroreflex sensitivity was significantly higher after vitamin C than after placebo infusion (placebo: 4.1±0.4 versus vitamin C: 5.3±0.5 ms/mm Hg, P<0.001). Low-frequency of R-R (LF_RR), expressed in normalized units (NU) (P<0.05); LF/high-frequency (HF) ratio (P<0.05), and LF of SBP (LF_SBP) decreased significantly; HF power (P<0.05), and -HF (P<0.001) increased. Conversely, in the control group, baroreflex sensitivity and other spectral variables measured at baseline, after placebo, and after vitamin C infusion remained statistically unchanged (placebo: 10.2±0.1 versus vitamin C: 10.0±0.2 ms/mm Hg, NS). Acute administration of vitamin C at high doses improves baroreflex sensitivity and vagal sinus modulation in patients with CHF. This finding could have notable clinical and therapeutic implications. Key issues to understand are whether the beneficial effect persists during chronic administration and whether it helps to improve survival.

Key Words: autonomic nervous system • baroreflex • vitamins • heart failure • endothelium • vasoconstriction

This article has been cited by other articles:

				E. Peeters, A. Neyt, F. Beckers, S. De Smet, A. E. Aubert, and R. Geers Influence of supplemental magnesium, tryptophan, vitamin C, and vitamin E on stress responses of pigs to vibration J Anim Sci, July 1, 2005; 83(7): 1568 - 1580. [Abstract] [Full Text] [PDF]

				B. A. Mullan, C. N. Ennis, H. J. P. Fee, I. S. Young, and D. R. McCance Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1262 - H1268. [Abstract] [Full Text] [PDF]

				K. D. Monahan, I. Eskurza, and D. R. Seals Ascorbic acid increases cardiovagal baroreflex sensitivity in healthy older men Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2113 - H2117. [Abstract] [Full Text] [PDF]

				A. K. Nightingale, M. Schmitt, M. P. Frenneaux, G. Piccirillo, M. Nocco, A. Moise, M. Lionetti, C. Naso, and S. D. C. V. Marigliano Letter: Vitamin C in Heart Failure: Hype or Hope? Hypertension, February 1, 2004; e6(2): . [Full Text] [PDF]